Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions may be administered by an inhaler device described herein. The powdery pharmaceutical compositions may be administered by gummies described herein.

Abstract: A diving safety system comprising a floatation buoy acting as a diving line spool, a slip ring within the buoy containing components of a wired and/or wireless electrical communication system allowing an underwater diver to communicate with a boat or shore-based persons, with a method of use.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions herein can contain particles that are encapsulated with multiple layers of material.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions herein can contain particles that are encapsulated with multiple layers of material.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions described herein can contain cellular material and can be microencapsulated to increase preservation of the cellular material. The powdery pharmaceutical compositions can be administered by numerous methods, such as by inhalation administration or oral administration.

Abstract: A probe microscope comprising a probe array with an array of probes, each probe comprising a cantilever and a probe tip. A lighting system comprises a plurality of light sources. Each light source is configured to output a respective light beam. A lens array comprises an array of lenses. Each source lens is positioned to receive a respective one of the light beams from the lighting system. A collector lens is configured to collect the light beams from the lens array. An objective lens is configured to receive the light beams from the collector lens and focus each light beam onto the cantilever of a respective one of the probes. The lighting system is configured to modulate a power of the light beams to actuate the probes, and the lighting system is configured to modulate the power of some or all of the light beams independently.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions may be administered by an inhaler device described herein. The powdery pharmaceutical compositions may be administered by gummies described herein.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions may be administered by an inhaler device described herein. The powdery pharmaceutical compositions may be administered by gummies described herein.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions may be administered by an inhaler device described herein. The powdery pharmaceutical compositions can comprise encapsulated epinephrine or encapsulated insulin.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions can be administered by an inhaler device described herein.

Abstract: Provided herein are pharmaceutical or dietary supplement compositions, kits comprising pharmaceutical or dietary supplement compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical or dietary supplement composition compositions described herein can be administered orally. The pharmaceutical or dietary supplement compositions can be administered by a capsule described herein.

Abstract: A diving safety system comprising a floatation buoy acting as a diving line spool, a slip ring within the buoy containing components of a wired and/or wireless electrical communication system allowing an underwater diver to communicate with a boat or shore-based persons, with a method of use.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions can be administered by an inhaler device described herein.

Abstract: A robotic vehicle (10) may include a chassis supporting a storage tank in which an aqueous solution is contained, a mobility assembly operably coupled to the chassis to provide mobility for the robotic vehicle about a service area (20), a positioning module (60) configured to provide guidance for the robotic vehicle (10) during transit of the robotic vehicle (10) over the service area (20), a spray assembly (90) and control circuitry (12).

Abstract: Systems and methods described herein may generate a digital payment token associated with a payor-user indicating the status of a payment obligation of the payor-user. The systems and methods may generate a first block containing the digital payment token and append the first block to a blockchain. The systems and methods may receive a confirmation message from a third-party transaction server that the payor-user has either fully or partially fulfilled his or her payment obligation. Based upon the confirmation message, the systems and methods may retrieve the block containing the digital payment token and update the digital payment token to generate an updated digital payment token. The system and methods may generate a second block containing the updated digital payment token to supersede the first block and append the second block to the blockchain. The updated digital payment token may indicate that the digital payment token has expired.

Abstract: Systems and methods described herein may generate a digital payment token associated with a payor-user indicating the status of a payment obligation of the payor-user. The systems and methods may generate a first block containing the digital payment token and append the first block to a blockchain. The systems and methods may receive a confirmation message from a third-party transaction server that the payor-user has either fully or partially fulfilled his or her payment obligation. Based upon the confirmation message, the systems and methods may retrieve the block containing the digital payment token and update the digital payment token to generate an updated digital payment token. The system and methods may generate a second block containing the updated digital payment token to supersede the first block and append the second block to the blockchain. The updated digital payment token may indicate that the digital payment token has expired.

Abstract: Embodiments disclosed herein provide systems and methods for digital identity management and permission controls within distributed network nodes. A network node may receive a request to generate a new digital identity record for an entity. The network node may retrieve a template based on an entity type; and receive information, reference documents, and biometric information for the new digital identity record. The network node may associate and store the received information to the data fields in the new digital identity record, generate respective one directional cryptographic hashes of the reference documents and the biometric information, and store the hashes in the new digital identity record while storing the reference documents and biometric information in a non-blockchain repository. The network node may generate a digital identity record block for the new digital identity record, encrypt the digital identity record block, and append the encrypted block to the latest valid blockchain.

Abstract: An apparatus, system and method for deactivating problematic secondary content are provided. This approach involves a deactivator component receiving data associated with an indication of a change to one or more secondary contents, a secondary content playback report, and/or a secondary content quality of experience (QoE) via data sources. After identifying the problematic secondary content, the deactivator component may request a secondary content provider to deactivate the problematic secondary content by deactivating a target resource associated with the secondary content instance, the secondary content, the secondary content unit, or the placement. In particular, the deactivator component may also provide feedback or reason for deactivating the secondary content.

Abstract: An apparatus, system and method for deactivating problematic secondary content are provided. This approach involves a deactivator component receiving data associated with an indication of a change to one or more secondary contents, a secondary content playback report, and/or a secondary content quality of experience (QoE) via data sources. After identifying the problematic secondary content, the deactivator component may request a secondary content provider to deactivate the problematic secondary content by deactivating a target resource associated with the secondary content instance, the secondary content, the secondary content unit, or the placement. In particular, the deactivator component may also provide feedback or reason for deactivating the secondary content.

Abstract: An improved system and method for bracing, transporting, assembling, and disassembly of drilling equipment at oil and gas land-based well sites. The system has a substructure with side boxes support bracing that are in a scissor jack (or grand plié) style bracing with telescoping tension link(s), linking pins, and vertical hydraulic cylinders. These linking pins are set after raising the substructure and secure the telescoping tension link, support arms, and support bracing in place to maintain the integrity of the substructure. Alternatively the system has a substructure with side boxes support bracing that are in a scissor jack (or grand plié) style bracing with screw jacks and a means of stabilization during substructure raising.